Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed.
作者： Ida Robertsen , Anders Åsberg , Aleksander Olsen Ingerø , Nils Tore Vethe , Sara Bremer
DOI: 10.1097/TP.0000000000000384
关键词:
摘要: BackgroundProper bioequivalence studies comparing original with generic immunosuppressive drugs in patients are limited, especially the increasing population of elderly renal transplant recipients. We performed an open-label, single-center, prospective, randomized, cross-over study and compared s
wkhealth.com参考文章(32)
G. B. Klintmalm, Immunosuppression, generic drugs and the FDA. American Journal of Transplantation. ,vol. 11, pp. 1765- 1766 ,(2011) , 10.1111/J.1600-6143.2011.03616.X
C. J. Yates, S. Fourlanos, J. Hjelmesaeth, P. G. Colman, S. J. Cohney, New-onset diabetes after kidney transplantation-changes and challenges. American Journal of Transplantation. ,vol. 12, pp. 820- 828 ,(2012) , 10.1111/J.1600-6143.2011.03855.X
J. D. Momper, T. A. Ridenour, K. S. Schonder, R. Shapiro, A. Humar, R. Venkataramanan, The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. American Journal of Transplantation. ,vol. 11, pp. 1861- 1867 ,(2011) , 10.1111/J.1600-6143.2011.03615.X
J. Trofe-Clark, S. Gabardi, L. McDevitt-Potter, R. R. Alloway, Immunosuppression, generic drugs and the FDA. American Journal of Transplantation. ,vol. 12, pp. 792- 793 ,(2012) , 10.1111/J.1600-6143.2011.03875.X
L. V. Riella, S. Gabardi, A. Chandraker, Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation American Journal of Transplantation. ,vol. 12, pp. 1975- 1982 ,(2012) , 10.1111/J.1600-6143.2012.04084.X
Teun van Gelder, None, European society for organ transplantation advisory committee recommendations on generic substitution of immunosuppressive drugs. Transplant International. ,vol. 24, pp. 1135- 1141 ,(2011) , 10.1111/J.1432-2277.2011.01378.X
V. Haufroid, P. Wallemacq, V. VanKerckhove, L. Elens, M. De Meyer, D. C. Eddour, J. Malaise, D. Lison, M. Mourad, CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. American Journal of Transplantation. ,vol. 6, pp. 2706- 2713 ,(2006) , 10.1111/J.1600-6143.2006.01518.X
Pierre Wallemacq, Victor W Armstrong, Merce Brunet, Vincent Haufroid, David W Holt, Atholl Johnston, Dirk Kuypers, Yannick Le Meur, Pierre Marquet, Michael Oellerich, Eric Thervet, Burkhand Toenshoff, Nas Undre, Lutz T Weber, Ian S Westley, Michel Mourad, Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Therapeutic Drug Monitoring. ,vol. 31, pp. 139- 152 ,(2009) , 10.1097/FTD.0B013E318198D092
R. D. Bloom, J. Trofe-Clark, A. Wiland, R. R. Alloway, A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients Clinical Transplantation. ,vol. 27, ,(2013) , 10.1111/CTR.12256
Pierre Wallemacq, Jean-Sebastien Goffinet, Susan OʼMorchoe, Thomas Rosiere, Gregory T Maine, Myriam Labalette, Giuseppe Aimo, Diana Dickson, Ed Schmidt, Reinhard Schwinzer, Rainer W Schmid, Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Therapeutic Drug Monitoring. ,vol. 31, pp. 198- 204 ,(2009) , 10.1097/FTD.0B013E31819C6A37